124 related articles for article (PubMed ID: 19935271)
1. Clinical outcome in children with culture-negative acute otitis media.
Leibovitz E; Nakash E; Givon-Lavi N; Greenberg D; Satran R; Raiz S; Piglansky L; Leiberman A; Dagan R
Pediatr Infect Dis J; 2009 Dec; 28(12):1105-10. PubMed ID: 19935271
[TBL] [Abstract][Full Text] [Related]
2. Recurrent acute otitis media occurring within one month from completion of antibiotic therapy: relationship to the original pathogen.
Leibovitz E; Greenberg D; Piglansky L; Raiz S; Porat N; Press J; Leiberman A; Dagan R
Pediatr Infect Dis J; 2003 Mar; 22(3):209-16. PubMed ID: 12634580
[TBL] [Abstract][Full Text] [Related]
3. Failure to achieve early bacterial eradication increases clinical failure rate in acute otitis media in young children.
Dagan R; Schneider S; Givon-Lavi N; Greenberg D; Leiberman A; Jacobs MR; Leibovitz E
Pediatr Infect Dis J; 2008 Mar; 27(3):200-6. PubMed ID: 18277926
[TBL] [Abstract][Full Text] [Related]
4. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children.
Piglansky L; Leibovitz E; Raiz S; Greenberg D; Press J; Leiberman A; Dagan R
Pediatr Infect Dis J; 2003 May; 22(5):405-13. PubMed ID: 12792379
[TBL] [Abstract][Full Text] [Related]
5. Persistence of pathogens despite clinical improvement in antibiotic-treated acute otitis media is associated with clinical and bacteriologic relapse.
Asher E; Dagan R; Greenberg D; Givon-Lavi N; Libson S; Porat N; Leiberman A; Leibovitz E
Pediatr Infect Dis J; 2008 Apr; 27(4):296-301. PubMed ID: 18379372
[TBL] [Abstract][Full Text] [Related]
6. Epidemiologic and microbiologic characteristics of culture-positive spontaneous otorrhea in children with acute otitis media.
Leibovitz E; Serebro M; Givon-Lavi N; Greenberg D; Broides A; Leiberman A; Dagan R
Pediatr Infect Dis J; 2009 May; 28(5):381-4. PubMed ID: 19319018
[TBL] [Abstract][Full Text] [Related]
7. A multicenter, open label, double tympanocentesis study of high dose cefdinir in children with acute otitis media at high risk of persistent or recurrent infection.
Arguedas A; Dagan R; Leibovitz E; Hoberman A; Pichichero M; Paris M
Pediatr Infect Dis J; 2006 Mar; 25(3):211-8. PubMed ID: 16511382
[TBL] [Abstract][Full Text] [Related]
8. Can acute otitis media caused by Haemophilus influenzae be distinguished from that caused by Streptococcus pneumoniae?
Leibovitz E; Satran R; Piglansky L; Raiz S; Press J; Leiberman A; Dagan R
Pediatr Infect Dis J; 2003 Jun; 22(6):509-15. PubMed ID: 12799507
[TBL] [Abstract][Full Text] [Related]
9. Bacteriologic and clinical efficacy of oral gatifloxacin for the treatment of recurrent/nonresponsive acute otitis media: an open label, noncomparative, double tympanocentesis study.
Leibovitz E; Piglansky L; Raiz S; Greenberg D; Hamed KA; Ledeine JM; Press J; Leiberman A; Echols RM; Pierce PF; Jacobs MR; Dagan R
Pediatr Infect Dis J; 2003 Nov; 22(11):943-9. PubMed ID: 14614364
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy and safety evaluation of cefaclor vs amoxycillin + clavulanate in children with Acute Otitis Media (AOM).
Aggarwal M; Sinha R; Murali MV; Trihan P; Singhal PK
Indian J Pediatr; 2005 Mar; 72(3):233-8. PubMed ID: 15812119
[TBL] [Abstract][Full Text] [Related]
11. Clinical/otologic score before and during treatment of acute otitis media.
Satran R; Leibovitz E; Raiz S; Piglansky L; Press J; Leiberman A; Dagan R
Acta Paediatr; 2007 Dec; 96(12):1814-8. PubMed ID: 17953728
[TBL] [Abstract][Full Text] [Related]
12. Use of C-reactive protein in differentiation between acute bacterial and viral otitis media.
Tejani NR; Chonmaitree T; Rassin DK; Howie VM; Owen MJ; Goldman AS
Pediatrics; 1995 May; 95(5):664-9. PubMed ID: 7724300
[TBL] [Abstract][Full Text] [Related]
13. Acute otitis media disease management.
Pichichero ME; Casey JR
Minerva Pediatr; 2003 Oct; 55(5):415-38. PubMed ID: 14608265
[TBL] [Abstract][Full Text] [Related]
14. Acute otitis media caused by Streptococcus pyogenes in children.
Segal N; Givon-Lavi N; Leibovitz E; Yagupsky P; Leiberman A; Dagan R
Clin Infect Dis; 2005 Jul; 41(1):35-41. PubMed ID: 15937760
[TBL] [Abstract][Full Text] [Related]
15. Is bilateral acute otitis media clinically different than unilateral acute otitis media?
Leibovitz E; Asher E; Piglansky L; Givon-Lavi N; Satran R; Raiz S; Slovik Y; Leiberman A; Dagan R
Pediatr Infect Dis J; 2007 Jul; 26(7):589-92. PubMed ID: 17596799
[TBL] [Abstract][Full Text] [Related]
16. Comparison of study designs for acute otitis media trials.
Pichichero ME; Casey JR
Int J Pediatr Otorhinolaryngol; 2008 Jun; 72(6):737-50. PubMed ID: 18400312
[TBL] [Abstract][Full Text] [Related]
17. Rates of tympanic membrane closure in double-tympanocentesis studies.
Slovik Y; Raiz S; Leiberman A; Puterman M; Dagan R; Leibovitz E
Pediatr Infect Dis J; 2008 Jun; 27(6):490-3. PubMed ID: 18449065
[TBL] [Abstract][Full Text] [Related]
18. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
[TBL] [Abstract][Full Text] [Related]
19. A prospective observational study of 5-, 7-, and 10-day antibiotic treatment for acute otitis media.
Pichichero ME; Marsocci SM; Murphy ML; Hoeger W; Francis AB; Green JL
Otolaryngol Head Neck Surg; 2001 Apr; 124(4):381-7. PubMed ID: 11283494
[TBL] [Abstract][Full Text] [Related]
20. Randomized, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media.
Dunne MW; Latiolais T; Lewis B; Pistorius B; Bottenfield G; Moore WH; Garrett A; Stewart TD; Aoki J; Spiegel C; Boettger D; Shemer A
J Antimicrob Chemother; 2003 Sep; 52(3):469-72. PubMed ID: 12888586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
